April 29 (Reuters) - Some U.S. stocks to watch on Monday:
Wall Street was set for a higher open on Monday, buoyed by the formation of a broad coalition government in Italy which ended two months of political uncertainty and boosted an appetite for risky assets, as investors braced for major economic news this week. S&P 500 futures were up 0.35 percent, Dow Jones industrial average futures were up 0.32 percent and Nasdaq 100 futures rose 0.45 percent.
** MOODY‘S CORP, Friday close $55.12, up 5 pct premarket
** MCGRAW-HILL COS INC, Friday close $52, up 4 pct premarket
Moody’s Investors Service and Standard & Poor’s on Friday said they have settled two long-running lawsuits seeking to hold them responsible for misleading investors about the safety of risky debt vehicles that they had rated. The lawsuits had accused Moody‘s, a unit of Moody’s Corp, and S&P, a unit of McGraw-Hill Cos, of negligent misrepresentation over their activities regarding the Cheyne and Rhinebridge structured investment vehicles (SIVs).
** CONCEPTUS INC, Friday close $25.90, up 20 pct premarket
Germany’s Bayer AG has agreed to buy the U.S. contraceptive devices maker for $1.1 billion, aiming to underpin its position as the world’s largest women’s healthcare provider.
** SINA CORP, Friday close $50.3, up 23 pct premarket
** YAHOO INC, Friday close $24.68, up 2 pct premarket
China’s largest Internet portal and media website, said e-commerce company Alibaba Group has bought an 18 percent stake in its microblogging service Weibo for about $586 million, valuing Weibo at more than $3 billion. Yahoo owns a large stake in Alibaba Group.
** J.C. PENNEY CO INC, Friday close $17, up 5 pct premarket
The retailer said on Monday it had lined up a five-year, $1.75 billion financing package from Goldman Sachs Group Inc , the latest move by the struggling company to shore up its finances.
** NORTHERN TIER ENERGY LP, Friday close $25.44, up 3 pct premarket
The oil refiner and retailer said late on Friday that adjusted earnings before interest, taxes, depreciation and amortization for January-March quarter is expected to be higher, partly because the company sold more refined products.
** ACTAVIS INC, Friday close $100.94, up 6 pct premarket
A proposed merger of Valeant Pharmaceuticals International Inc and Actavis was put on hold after the two drugmakers failed to agree on terms of a deal that would have created a healthcare giant with a combined market value of $35 billion, a person familiar with the situation told Reuters on Saturday.
** TENET HEALTHCARE INC, Friday close $41.16, up 9 pct premarket
** HCA HOLDINGS INC, Friday close $38.25, up 5.3 pct premarket
** HEALTH MANAGEMENT ASSOCIATES INC, Friday close $11.20, up 5 pct premarket
The U.S. government health insurance plan for seniors proposed on Friday a 0.8 percent increase in hospital payments for fiscal 2014 - a level analysts said was within expectations.
Baird said on Monday that the payment increase was better than expected for the hospital operators industry, with Tenet and HCA being “the biggest winners.”
** MEDIDATA SOLUTIONS INC, Friday close $54.06, up 7 pct premarket
The company, which provides software to drugmakers for clinical analysis, reported better-than-expected first-quarter results.
** GANNETT CO INC, Friday close $20.54, down 1.7 pct premarket
Barclays cut its rating on shares of the largest U.S. newspaper chain to “underweight” from “equalweight”, according to theflyonthewall.com.
** NII HOLDINGS INC, Friday close $8.83, up 6 pct premarket
Wells Fargo raised its rating on the Latin American telecom service provider’s stock to “outperform” from “market perform” as it expects the company to divest its tower assets at a higher price.
“We believe NII will divest of its 4,500 towers in Mexico and Brazil at a price higher than the Street expects,” Wells Fargo analyst Jennifer Fritzsche said in a note.
** EATON CORP PLC, Friday close $58.65, up 2 pct premarket
The Electrical and hydraulic systems maker reported a better-than-expected 28 percent rise in operating profit as its acquisition of Cooper Industries last year propped up sales in its electrical business.
** BIOGEN IDEC INC, Friday close $213.59, up 2.3 pct premarket
ISI Group analyst Mark Schoenebaum said IMS Health and Wolters Kluwer’s latest data on prescriptions of Biogen’s oral multiple sclerosis drug, Tecfidera, showed “amazing” growth in the drug’s adoption. The analyst said he now predicts Tecfidera sales could exceed $450 million in the United States this year, ahead of consensus estimates of $240 million to $300 million. (Compiled by Maria Ajit Thomas in Bangalore; Editing by Roshni Menon)